<DOC>
	<DOC>NCT01943136</DOC>
	<brief_summary>This study will be an investigator-blinded, patient-blinded, assessor-blinded, parallel-group, randomized clinical trial. It aims to evaluate the efficacy of one-week twice-daily application of topical papaya leaf extract ointment compared to mupirocin ointment in achieving clinical cure among patients with impetigo.</brief_summary>
	<brief_title>The Efficacy and Safety of Topical Papaya (Carica Papaya) Leaf Extract 1% Ointment Versus Mupirocin 2% Ointment in the Treatment of Limited Impetigo: a Randomized, Double-blind, Controlled Clinical Trial</brief_title>
	<detailed_description />
	<mesh_term>Impetigo</mesh_term>
	<mesh_term>Mupirocin</mesh_term>
	<criteria>Healthy Filipino patients aged 1 year and above with primary impetigo, limited to less than or equal to 1% BSA, and involving only one body area Extensive impetigo (&gt;1% BSA), affecting more than one body area Systemic involvement (lymphadenopathy, fever, sepsis) Chronic comorbidities like diabetes mellitus, malignancy, chronic venous insufficiency Concurrent immunosuppressive therapy Patients â‰¤ 1 year Pregnant &amp; lactating patients</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>impetigo</keyword>
	<keyword>papaya extract ointment</keyword>
</DOC>